Trials / Completed
CompletedNCT00845858
Efficacy and Safety of Metoclopramide Nasal Spray Solution in Diabetic Patients With Gastroparesis
A Multicenter, Randomized, Double-Blind, Placebo Controlled, Parallel Group, Dose-Ranging Clinical Study to Evaluate the Efficacy and Safety of Metoclopramide Nasal Spray Solution in Diabetic Subjects With Gastroparesis
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 287 (actual)
- Sponsor
- Evoke Pharma · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate the safety and the effectiveness of two doses of metoclopramide nasal spray solution, 10 mg and 14 mg, compared to placebo in reducing the symptoms of diabetic gastroparesis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | metoclopramide | 30 minutes before meals and at bedtime for 4 weeks |
| DRUG | Placebo | 30 minutes before meals and at bedtime |
Timeline
- Start date
- 2009-04-01
- Primary completion
- 2011-12-01
- Completion
- 2011-12-01
- First posted
- 2009-02-18
- Last updated
- 2014-06-27
- Results posted
- 2014-06-17
Locations
65 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00845858. Inclusion in this directory is not an endorsement.